CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Open-market buy Pres and CEO bought 6,500 shares at $7.74 ($50,278)
- 4 Open-market sale Director sold 59,240 shares at an average $12.50 ($740,658)
- 4 Open-market sale Chief Scientific Officer sold 30,837 shares at an average $12.51 ($385,639)
- 4 Open-market sale Chief Financial Officer sold 1,894 shares at an average $12.45 ($23,579)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $13.06 ($65,311)
- 4 Open-market sale Chief Business Officer sold 4,267 shares at $13.89 ($59,272)
- 4 Open-market sale Director sold 30,000 shares at an average $16.66 ($499,923)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Business Officer acquired 11,250 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Director gave 4,000 shares (gift)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 40,000 shares at an average $15.11 ($604,556)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $15.88 ($79,412)
- 4 Open-market sale Director sold 53,926 shares at an average $17.05 ($919,589)
- 4 Open-market sale Director sold 41,174 shares at an average $17.01 ($700,355)
- 4 Open-market sale Director sold 52,037 shares at an average $16.57 ($862,109)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $15.98 ($79,908)
Page 7 of 21 · 414 filings